Genentech reviews

Heavy workload, easy to get looked over unless you stand up for yourself. Roche integration has led to uncertainty about the future.

Very high pressure and the corporate structure and conflicting institutional imperatives make it very hard to get things done. this is particular true in the various marketing and sales related functions. Clinical and legal set the agenda in the company and take very conservative positions in terms of marketing and sales efforts. That is fine but the people at the top of marketing and the commercial side of the company are continually putting pressure to deliver a bigger number and develop innovative and cutting edge programs. As a result commerical is continually butting heads with legal and clinical and the conflict takes place at the level of product manager to attorney. The product manager has no leverage in that discussion but they get little support from their upper management or forgiveness when they can't deliver. Genentech is moving more and more towards being simply another big pharma company. The merger with Roche will accelerate that. The mis-match in culture between those big pharma people being brought in to run the company and the people who came to Genentech because of its more "independent" reputation has made it difficult for many of those people to move up in the company.